Luina Bio and XING Technologies have formed a partnership to co-develop and manufacture a SARS-CoV-2 diagnostic kit. The COVID-19 detection technology is based on a temperature-stable molecule utilizing XING patented technology.   XING is looking to fast-track the development and regulatory approval of the diagnostic kit to meet customer needs in the U.S., Europe and the pan-Asian region. These customers have been looking for a fast and accurate point-of-care antigen test as a superior alternate...